Quantitating tissue specificity of human genes to facilitate biomarker discovery

We describe a method to identify candidate cancer biomarkers by analyzing numeric approximations of tissue specificity of human genes. These approximations were calculated by analyzing predicted tissue expression distributions of genes derived from mapping expressed sequence tags (ESTs) to the human genome sequence using a binary indexing algorithm. Tissue-specificity values facilitated high-throughput analysis of the human genes and enabled the identification of genes highly specific to different tissues. Tissue expression distributions for several genes were compared to estimates obtained from other public gene expression datasets and experimentally validated using quantitative RT-PCR on RNA isolated from several human tissues. Our results demonstrate that most human genes ( approximately 98%) are expressed in many tissues (low specificity), and only a small number of genes possess very specific tissue expression profiles. These genes comprise a rich dataset from which novel therapeutic targets and novel diagnostic serum biomarkers may be selected.

[1]  P. Kenemans,et al.  Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values. , 1996, American journal of obstetrics and gynecology.

[2]  J. Beechem,et al.  Bioinformatics Methods for Prioritizing Serum Biomarker , 2022 .

[3]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Bast,et al.  An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. , 1988, Gynecologic oncology.

[5]  M. Vaidya,et al.  Database on monoclonal antibodies to cytokeratins. , 2004, Oral oncology.

[6]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983 .

[7]  G. Rustin,et al.  Role of tumour markers in monitoring epithelial ovarian cancer , 2000, British Journal of Cancer.

[8]  George Vasmatzis,et al.  Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. , 2002, Cancer research.

[9]  Yan Zhang,et al.  GEPIS - quantitative gene expression profiling in normal and cancer tissues , 2004, Bioinform..

[10]  S. Benowitz.  Biomarker boom slowed by validation concerns. , 2004, Journal of the National Cancer Institute.

[11]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[12]  J. Beechem,et al.  Bioinformatics methods for prioritizing serum biomarker candidates. , 2006, Clinical chemistry.

[13]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[14]  F. J. Anscombe,et al.  THE TRANSFORMATION OF POISSON, BINOMIAL AND NEGATIVE-BINOMIAL DATA , 1948 .

[15]  R. Bast,et al.  Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[16]  G. Bannon,et al.  CA 125 antigen in human amniotic fluid and fetal membranes , 1987, American journal of obstetrics and gynecology.

[17]  B. Haendler,et al.  Mouse androgen‐dependent epididymal glycoprotein crisp‐1 (DE/AEG): Isolation, biochemical characterization, and expression in recombinant form , 1995, Molecular reproduction and development.

[18]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology , 2003, Nucleic Acids Res..

[19]  E. Pauwels,et al.  Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[20]  T. O'brien,et al.  Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm. , 1990, American journal of obstetrics and gynecology.

[21]  B. Yin,et al.  Synthesis and Secretion of the Ovarian Cancer Antigen CA 125 by the Human Cancer Cell Line NIH:OVCAR-3 , 2000, Tumor Biology.

[22]  C. V. Jongeneel,et al.  An atlas of human gene expression from massively parallel signature sequencing (MPSS). , 2005, Genome research.

[23]  P. McCullagh,et al.  Generalized Linear Models , 1984 .

[24]  I. Pastan,et al.  Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.